Biography of Zach Weinberg: Bridging Innovation from Software to Biotech
Biography of Zach Weinberg:
Zach Weinberg is the CEO and Co-Founder of Curie.Bio. Before
starting this venture, he spent 15 years building software companies. He
co-founded Invite Media, which Google acquired in 2010, and Flatiron Health,
acquired by Roche in 2018.
Educational Background:
Zach holds a degree in Economics and Entrepreneurship from
the University of Pennsylvania's Wharton School. His academic background
equipped him with the knowledge and skills to navigate the complexities of
entrepreneurship and business management.
Zach Weinberg's Diverse Career Journey
Zach Weinberg is the Chief Executive Officer and Co-Founder
of Curie.Bio. Additionally, he acts as an advisor at Great Oaks Venture Capital
and serves as a General Partner at Operator Partners.
Professional Background:
Prior to his involvement with Curie.Bio, Zach co-founded and
served as President and Chief Operating Officer at Flatiron Health. Before
Flatiron, he co-founded and held the same roles at Invite Media, an advertising
technology company based in New York City.
Transition to Biotech:
After spending 15 years building software companies like
Invite Media and Flatiron Health, Zach shifted his focus to biotech. His
software ventures were successfully acquired, with Invite Media being bought by
Google in 2010 and Flatiron Health acquired by Roche in 2018.
Zach Weinberg's Career Journey
Curie.Bio - Founder:
Since January 2022, Zach Weinberg has been dedicating his
efforts to Curie.Bio as a Founder. In this role, he spearheads the company's
mission and strategic direction, leveraging his expertise in entrepreneurship
and technology to drive growth and innovation.
Angel Investor:
For over 14 years, starting from June 2010, Zach has been an
active Angel Investor, supporting numerous startups across various industries.
His investment portfolio reflects his commitment to fostering innovation and
entrepreneurship in the startup ecosystem.
Flatiron Health - Co-Founder, President & COO (Acquired
by Roche):
From June 2012 to March 2021, Zach played a pivotal role as
Co-Founder, President, and COO at Flatiron Health. During his tenure, he
contributed to the company's success and eventual acquisition by Roche,
demonstrating his leadership and strategic acumen.
Google - Vacation:
From June 2010 to June 2012, Zach briefly joined Google,
possibly taking a break or exploring new opportunities. This experience may
have provided valuable insights and perspectives that he later applied to his
entrepreneurial endeavors.
Invite Media - Co-Founder, President & COO (Acquired by
Google):
From March 2007 to June 2012, Zach co-founded Invite Media
and served as President and COO. His contributions were instrumental in the
company's growth and eventual acquisition by Google, showcasing his ability to
build and scale successful ventures.
EatNow.com - Co-Founder; President:
Zach co-founded EatNow.com in April 2005 and served as
President until June 2006 when the company was privately sold. This early
entrepreneurial experience likely laid the foundation for his subsequent
ventures, providing valuable lessons and insights.
Zach Weinberg's career journey exemplifies his
entrepreneurial spirit and dedication to driving innovation in the technology
and healthcare sectors. From co-founding successful startups to nurturing
emerging companies as an angel investor, Zach's contributions have made a
significant impact on the entrepreneurial landscape.
Diverse Skill Set:
Zach's diverse experiences across software and biotech
industries demonstrate his versatility and adaptability as a leader. His
transition from software to biotech reflects his ability to leverage expertise
in different domains to drive innovation and success.
Contributions to Venture Capital:
In addition to his entrepreneurial endeavors, Zach
contributes to the venture capital landscape through his advisory roles and
partnerships. His insights and expertise add value to the startup ecosystem,
helping aspiring entrepreneurs turn their ideas into successful ventures.
Biography of Zach Weinberg: Bridging Innovation from Software to Biotech / Investor Zach Weinberg:
The Software Industry Experience:
Weinberg highlights two key factors in the software
industry's growth: affordability and flexibility. Cloud computing has made it
cheaper to start software companies, and mistakes can be rectified quickly and
inexpensively.
The Challenges in Biotech:
While biotech has become more accessible, mistakes are
costly. Errors in target selection, experimental design, or vendor selection
can lead to significant setbacks. Traditionally, biotech startups require large
investments and years of work before achieving meaningful progress.
Curie.Bio's Solution:
Curie.Bio aims to revolutionize biotech by combining
expertise with investment. Their model allows founders to access top talent and
resources while minimizing risks. By acting as both a partner and investor,
Curie.Bio empowers entrepreneurs to navigate the complexities of drug discovery
more efficiently.
Zach Weinberg's Angel Investing Portfolio
Diverse Investments:
Zach Weinberg is an active angel investor with a portfolio
spanning over 30 technology startups across the United States. Some notable
investments include Bell Biosystems, Breakthrough.com, Care at Hand, DocPhin,
Doctor Evidence, Genomera, Meddik, Oscar, and Predilytics.
Tech Startup Support:
Through his angel investments, Zach supports a wide range of
technology startups, contributing both financially and strategically to their
growth and development. His investments cover various sectors, reflecting his
interest in diverse areas of innovation within the tech industry.
Commitment to Innovation:
Zach's involvement in multiple startups underscores his
commitment to fostering innovation and entrepreneurship. By providing funding
and guidance to emerging companies, he plays a vital role in fueling the growth
of innovative ideas and technologies.
Strategic Investment Choices:
Zach's investment portfolio showcases his strategic approach
to angel investing, with each investment representing a carefully chosen
opportunity with the potential for significant impact and success. His
selection of startups reflects his keen eye for promising ventures in the tech
sector.
Zach Weinberg's Investment Portfolio
Investment Rounds:
Zach Weinberg has participated in 33 investment rounds to
date. His most recent investment was in Scoop during a Series C Round on
November 18, 2022.
Notable Investments:
Among Zach's investment portfolio are notable companies such
as Plaid, Blue Apron, and BarkBox. These companies represent a diverse range of
industries and demonstrate Zach's interest in supporting innovative ventures
across different sectors.
Focused Sectors:
Zach's investments primarily target Enterprise Applications,
HealthTech, and several other sectors. This diversified approach allows him to
support startups addressing various challenges and opportunities in today's
evolving market landscape.
Geographic Reach:
Zach's investment portfolio spans companies located in the
United States, Israel, and another undisclosed location. This global footprint
reflects his willingness to explore investment opportunities beyond traditional
boundaries and support startups worldwide.
Supporting Healthcare and Technology:
Several of Zach's investments, such as Care at Hand, Doctor
Evidence, and Oscar, focus on healthcare and technology integration,
highlighting his interest in supporting advancements that improve healthcare
delivery and outcomes through innovative solutions.
Contributing to Startup Ecosystem:
As an active participant in the startup ecosystem, Zach's
angel investments contribute to the vibrancy and growth of the technology
industry. By backing early-stage startups, he helps fuel innovation and drive
positive change in various sectors.
Zach's Transition and Vision:
Zach's transition from software to biotech reflects his
commitment to innovation. Through Curie.Bio, he seeks to bridge the gap between
the two industries, leveraging his experience to support aspiring entrepreneurs
in biotech. Zach's vision is to accelerate the development of life-changing
medicines while making the process more accessible and less daunting.
Empowering Entrepreneurs:
Zach's journey underscores his entrepreneurial spirit and
dedication to driving positive change. By providing guidance, resources, and
investment, he enables founders to pursue their dreams and contribute to
advancements in healthcare and beyond.
Some recent companies where Zach Weinberg invested
- Grain - Communication Software
- Rightbound - Business/Productivity Software
- Thoropass - Business/Productivity Software
- Seso - Human Capital Services
- Connie Health - Managed Care
- Lolli - Financial Services
- Nym - Healthcare Technology Systems
- Fiverr Enterprise - Business/Productivity Software
- Daloopa - Financial Software
- Small Door Veterinary - Clinics/Outpatient Services
- HumanFirst – digital health technologies
- SolveBio – platform designed to monitor, gather, and secure genomic data
- BarkBox – subscription service for dog owners
- Voro – cloud platform automates real estate agent
- Troops – provides salesforce automation platform
- Klara – end-to-end virtual care platform
- Clause - digital contracting platform
Timeline:
April 2005 - June 2006: Co-founded and served as President
of EatNow.com, privately sold in May 2006.
March 2007 - June 2012: Co-founded Invite Media, acquired by
Google in June 2012.
June 2010 - June 2012: Joined Google, possibly taking a
break or exploring new opportunities.
June 2010 - Present: Actively involved as an angel investor,
supporting over 30 technology startups
June 2012 - March 2021: Co-founded, served as President
& COO of Flatiron Health, acquired by Roche in March 2021.
January 2022 - Present: Founded Curie.Bio, focusing on
revolutionizing biotech through innovation.
Various: Advisory roles at Great Oaks Venture Capital and
Operator Partners.
